切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - GLI - Protein polybromo-1 - CREBBP

10 件产品

每页
清除全部
  1. PFI 3
    B7744 PFI 3
    Target: Protein polybromo-1|SMARCA4|SMARCA2
    Summary: Polybromo 1和SMARCA4抑制剂
      ≥15.15 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. GANT61
    A1615 GANT61
     1 Citation
    Target: GLI
    Summary: GLI拮抗剂
      insoluble in DMSO
      insoluble in H2O
  8. SGC-CBP30
    A4491 SGC-CBP30
     2 Citation
    Target: CREBBP|EP300
    Summary: CREBBP/EP300 bromodomain抑制剂
      ≥20.05 mg/mL
      ≥4.67 mg/mL
  9. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain抑制剂
      ≥49.6 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页